ICD-10 E11.9: Billing Guide for Type 2 Diabetes

A biller opens a chart, sees “type 2 diabetes,” no mention of kidneys, nerves, or eyes, and reaches for E11.9 out of habit. That reflex used to be safe. FY2026 changed two things at once: the National Center for Health Statistics split off a new code for diabetes in remission, and CMS finished phasing in a risk-adjustment model that scores E11.9 differently than it did two years back.

HelloMDs codes diabetes charts across endocrinology, family practice, and internal medicine every week. Here’s what E11.9 covers now, what changed, and where the denials keep coming from.

What Does ICD-10 Code E11.9 Mean?

E11.9 is the ICD-10-CM code for type 2 diabetes mellitus without complications, a confirmed type 2 diabetes diagnosis where the chart records no nephropathy, neuropathy, retinopathy, or circulatory involvement. It sits inside category E11, in the endocrine and metabolic chapter, and it’s billable in office and outpatient visits.

• “No complications charted” doesn’t mean mild diabetes; a patient on three medications with tight control still qualifies if nothing else is documented that visit.
• Prediabetes isn’t part of this code family at all. That’s R73.03, since prediabetes isn’t yet a diabetes diagnosis.
• E11.9 ranks alongside hypertension and the annual wellness visit as one of the three most frequently billed diagnosis codes in primary care.
• An undocumented type defaults to E11.9; querying the provider for the actual type still beats defaulting.

How Does E11.9 Differ From E11.65 and Other E11 Codes?

E11.9 applies only when nothing else is charted. Once a note documents hyperglycemia, nephropathy, neuropathy, or a vascular complication, a more specific E11 code takes over, and a specific complication code can’t ride alongside the unspecified E11.9 on the same encounter; a payer reads that pairing as contradictory.

What Changed for E11.9 Under the FY2026 ICD-10-CM Update?

FY2026, effective October 1, 2025, added E11.A for type 2 diabetes without complications in remission, replacing the old workaround of billing plain E11.9 for a remission note. A strong A1c alone doesn’t earn E11.A; the provider has to write “remission,” or an equivalent statement, in the assessment first.

• “Controlled” or “well-controlled” isn’t remission, that’s still active disease, and still E11.9.
• Consensus criteria define remission as an A1c under 6.5% for at least three months off antidiabetic medication.
• Practices still charting E11.9 by habit for a remission visit are now coding to the wrong specificity level; some 2026 EHR coding-assist updates flag the gap, but chart language still has to support it.

Does E11.9 Affect HCC Risk Adjustment Scoring?

Yes. Under the CMS-HCC V28 model, fully phased in for payment year 2026, E11.9 maps to HCC 38, Diabetes without Chronic Complications, while any documented complication maps to the higher-weighted HCC 37. A chart supporting both categories only counts the higher one toward the patient’s risk score.

• A prior year’s E11.9 note doesn’t carry forward on its own; the diagnosis needs re-documentation each calendar year to count.
• Capture requires MEAT in the note: the diabetes has to be Monitored, Evaluated, Assessed, or Treated at that visit, not just listed.
• Coding a patient as E11.9 every visit while neuropathy or kidney disease sits documented elsewhere in the same chart under-states their risk score and creates the exact mismatch auditors search for.
• CMS is expanding Risk Adjustment Data Validation reviews from roughly 60 Medicare Advantage contracts a year to all 550 eligible contracts, with its coder workforce growing from 40 to 2,000; this specific gap is getting more eyes on it, not fewer. Confirm the exact weight against your plan’s current crosswalk.

What Documentation Backs Up an E11.9 Claim?

Payers want proof the absence of complications was actually checked, not assumed. “Type 2 diabetes, continue metformin,” with nothing else, invites a medical-necessity denial.

• An A1c or glucose value tied to the visit or a recent lab, not just a refill note.
• An assessment line ruling out nephropathy, neuropathy, and retinopathy by name, or stating no complications directly.
• Z79.4 for standing insulin use, or Z79.84 for standing oral hypoglycemic use, whenever the medication list calls for it. Z79.4 covers established long-term use only, not a short-term insulin bump during a hospital stay.

A clean example:

“Type 2 diabetes mellitus, well-controlled on metformin 1000 mg BID. A1c 6.8% (5/2026). No retinopathy, nephropathy, or neuropathy on exam. Continue current regimen, recheck A1c in 3 months.” That’s what separates a clean E11.9 claim from a denial.

Which CPT and HCPCS Codes Pair With E11.9?

Most E11.9 claims travel with an office-visit code and a lab code, sometimes joined by diabetes education, CGM, or chronic-care codes.

• 99213 or 99214: 99214 fits a visit where recent labs get reviewed, and medication gets adjusted; 99213 fits a stable, lower-complexity check-in
• 83036: The standard HbA1c lab code tied to ongoing E11.9 monitoring
• G0108 (individual) or G0109 (group): Diabetes self-management training, billable with a written order
• 95250/95251: CGM sensor placement and interpretation, for patients wearing a sensor
• 99490 or 99487: Chronic care management, once the patient has two or more qualifying chronic conditions
• Modifier -25 on the E/M code when a diabetes visit lands the same day as a preventive exam, skip it and the claim bundles or denies

Why Do E11.9 Claims Get Denied, and How Do You Stop It?

Three habits account for most of the diabetes denials. HelloMDs untangles: A missing Z-code, a thin assessment line, and a visit level that outpaces the note.

• A missing Z79.4/Z79.84 reads to a payer as an incomplete treatment picture.
• “Diabetes, stable,” with no lab value and no complication screen, gets denied for lack of medical necessity, the single most common hard denial across payers.
• A 99214 billed on a 99213-level note gets down-coded once the medical decision-making doesn’t back it up.

HelloMDs coders check the E11.9 (or E11.A) call, the Z-codes, and the visit level against the note before the claim goes out, across endocrinology, family practice, and internal medicine.

Conclusion:

Diabetes moves through more charts than almost any other diagnosis in primary care and endocrinology, a small coding habit repeated across hundreds of visits either leaves money on the table or draws audit attention. HelloMDs AAPC-certified coders check diabetes charts, specialty by specialty, catch the E11.9-versus-E11.A-versus-complication call before a claim goes out, and handle the appeal if a payer pushes back anyway. Send over a quarter’s worth of diabetes denials and see exactly where the pattern breaks.

Disclaimer:

This piece covers general FY2026 coding patterns, not compliance or legal advice, check current CMS and AMA guidance before coding a specific claim, and loop in your compliance lead for payer-specific questions.